Loading
Odyssey Health, Inc. Stock: price and insider trades · United States
Odyssey Health, Inc.: what insiders have been doing
Odyssey Health, Inc. has a thin disclosure history in our data (latest filing: 16 January 2024). New filings will appear here as soon as they are published. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
3
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended July 2024 · cache
US$0.01
Analyst consensus
Income statement
EBITDA-US$322.3k
Net income-US$905.8k0.0% margin
Valuation
Beta-1.39
Balance sheet & cash
Market capUS$1M
Total debtUS$1.6M
Free Cash Flow-US$1.2M
Profitability & ownership
ROA-217.9%
% insiders15.7%
% institutions0.0%
Last declaration on 16 January 2024
Declarations3 total
1,500,000 shares@ US$0.09100.0% of flowODYY - Common StockSEC:0001683168-24-000304:0
1,500,000 shares@ US$0.1633100.0% of flowCommon StockSEC:0001683168-22-006423:0
1,000,000 shares@ US$0.23100.0% of flowODYY common stock $0.001 par valueSEC:0001683168-22-004341:0
3 of 3 declarations
About Odyssey Health, Inc.
Odyssey Health, Inc. is a company focused on the healthcare and pharmaceutical sector. It is listed on the XNAS market.
